|
Guangzhou Dreampharm Biotechnology Co., Ltd.
|
Founded in 2014, Guangzhou Junmu Biotechnology Co., Ltd. is a high-tech enterprise integrating pharmaceutical research and development, biotechnology services (raw and auxiliary material production) and marketing; The company strictly follows the ISO9001 and CNAS management system for product quality management, and passed the on-site inspection of the China Institute for Food and Drug Control in 2019 and officially became a supplier of reference materials and raw materials.
Please contact customer service for the specific transaction price to confirm, contact information: 13502246435" |
Send Inquiry
|
|
Sinoway Industrial Co.Ltd.
|
|
Product name
|
Levetiracetam
|
|
CAS No.
|
102767-28-2
|
|
Molecular Formula
|
C4H11NO
|
|
Molecular Weight
|
170.211
|
|
Quality Standard
|
98% up by HPLC
|
|
Appearance
|
White or almost white powder
|
|
ANALYSIS
|
SPECIFICATION
|
RESULTS
|
|
Appearance
|
White or almost white powder
|
White powder
|
|
Assay
|
98.0% - 102.0%
|
99.2%
|
|
Water
|
≤ 0.5%
|
≤ 0.1%
|
|
Residue on ignition
|
≤ 0.1%
|
≤ 0.1%
|
|
Heavy metals
|
≤ 20ppm
|
< 20ppm
|
|
Enantiomeric purity
|
≤ 0.8%
|
Not detected
|
|
Conclusion
|
The sample complies with the USP standard.
|
Levetiracetam is a medication primarily used to treat certain types of seizures in patients with epilepsy. It is a white crystalline powder with a specific chemical structure, namely (S)-α-ethyl-2-oxo-1-pyrrolidine acetamide, and has a molecular formula of C8H14N2O2.
Levetiracetam functions primarily as an anticonvulsant drug, which means it is designed to prevent or reduce the frequency and severity of seizures in patients with epilepsy. The exact mechanism of action of Levetiracetam is believed to work by binding to a protein called synaptic vesicle protein 2A (SV2A) located in the presynaptic terminal of neurons. This binding is thought to interfere with the release of neurotransmitters, specifically glutamate, which is involved in the generation and spread of seizures. By modulating glutamate release, Levetiracetam can reduce the likelihood of seizures occurring.
|
Send Inquiry
|
Pharma Sources Insight June 2024: Globalization on the Go
